Anti-deltaNp63 [deltaNp63-1.1]

Cat. #162058

Anti-deltaNp63 [deltaNp63-1.1]

Cat. #: 162058

Sub-type: Primary antibody

Target: tumour protein p63 lacking the transactivation domain (TA)

Class: Monoclonal

Reactivity: Human ; mouse ; rat

Host: Mouse


This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.


Institute: Moravian Biotechnology

Tool Details
Target Details

Tool Details


  • Name: Anti-deltaNp63 [deltaNp63-1.1]
  • Clone: deltaNp63-1.1
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Molecular weight: 72 kDa
  • Reactivity: Human ; mouse ; rat
  • Host: Mouse
  • Description: Antibody created to detect the deltaN isoform of p63 (deltaNp63) with tumour suppressor role and differentiate from the TA (TAp63) isoforms of the same protein. Binding specificity: within MLYLENNAQTQFSE. No cross-reaction with p53 or p73 isoforms. Specificity verified by CRISPR-knockout and shRNA knockdown.
  • Immunogen: peptide MLYLENNAQTQFSE of tumour protein p63 (deltaN isoform) coupled to keyhole limpet hemocyanin
  • Isotype: IgG1 kappa
  • Production details: B cell donor: Splenocytes from mouse immunised with peptide MLYLENNAQTQFSE, Fusion partner: SP2

Target Details

  • Target: tumour protein p63 lacking the transactivation domain (TA)
  • Molecular weight: 72 kDa
  • Target background: p63 is a transcription factor of the p53 gene family, encoded by the TP63 gene located at chromosome 3q28. p63 exists as N-terminal isoforms that either contain (TAp63) or lack (deltaNp63) the p53-like transactivation domain at the N-terminus. C-terminal isoforms are produced by alternative splicing of 3' exons. TAp63 is involved in germ cell maintenance and myocyte differentiation, and is expressed in some lymphocytes and lymphomas/leukemias.
  • Epitope sequence: MLYLENNAQTQFSE sequence of tumour protein p63 (deltaN isoform)


  • Format: Liquid


  • Orzol et al. 2016. Tumour Biol. Aug:37(8):10133-40. PMID: 26825981
  • Galoczova et al. 2021. Virchows Arch. Apr:478(4):627-636. PMID: 33037932
  • Pokorna et al. 2022. Front Oncol. Jul 14:12:924354. PMID: 35912168